Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF), covering cash flow, earnings, and balance sheets.
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Income Statement & Financial Overview
Analyze Recordati Industria Chimica e Farmaceutica S.p.A.’s RCDTF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $679.96M | $598.48M | $557.41M | $577.85M |
| Cost of Revenue | $221.19M | $185.12M | $172.29M | $191.62M |
| Gross Profit | $458.77M | $413.36M | $385.12M | $386.23M |
| Gross Profit Ratio | $0.67 | $0.69 | $0.69 | $0.67 |
| R&D Expenses | $80.12M | $81.18M | $65.71M | $71.82M |
| SG&A Expenses | $181.39M | $183.65M | $149.34M | $164.92M |
| Operating Expenses | $263.006M | $278.60M | $219.56M | $234.59M |
| Total Costs & Expenses | $484.19M | $463.72M | $391.85M | $426.21M |
| Interest Income | $0.00 | $0.00 | -$88000.00 | $0.00 |
| Interest Expense | $26.46M | $21.67M | $18.46M | $20.43M |
| Depreciation & Amortization | $50.92M | $45.43M | $41.13M | $40.48M |
| EBITDA | $242.25M | $172.38M | $209.62M | $191.51M |
| EBITDA Ratio | $0.36 | $0.29 | $0.38 | $0.33 |
| Operating Income | $195.77M | $134.76M | $165.56M | $151.63M |
| Operating Income Ratio | $0.29 | $0.23 | $0.30 | $0.26 |
| Other Income/Expenses (Net) | -$30.91M | -$29.35M | -$15.53M | -$21.04M |
| Income Before Tax | $164.86M | $105.41M | $150.03M | $130.60M |
| Income Before Tax Ratio | $0.24 | $0.18 | $0.27 | $0.23 |
| Income Tax Expense | $39.82M | $27.30M | $37.002M | $28.82M |
| Net Income | $125.04M | $78.11M | $113.03M | $101.78M |
| Net Income Ratio | $0.18 | $0.13 | $0.20 | $0.18 |
| EPS | $0.61 | $0.38 | $0.55 | $0.49 |
| Diluted EPS | $0.60 | $0.37 | $0.54 | $0.49 |
| Weighted Avg Shares Outstanding | $206.36M | $206.30M | $209.12M | $206.24M |
| Weighted Avg Shares Outstanding (Diluted) | $209.10M | $208.84M | $209.12M | $209.12M |
Over the last four quarters, Recordati Industria Chimica e Farmaceutica S.p.A.'s revenue moved from $577.85M in Q2 2024 to $679.96M in Q1 2025. Operating income in Q1 2025 was $195.77M, with a strong operating margin of 29%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Recordati Industria Chimica e Farmaceutica S.p.A. remained robust at $242.25M, reflecting operational efficiency. Net income rose to $125.04M, with an EPS of $0.61. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan